Why is it crucial to reintegrate pathology into cancer research?

BioEssays

Volumn 33, Issue 7, 2011, Pages 490-498

  Rodriguez Canales, Jaime ^a   Eberle, Franziska C ^a,b   Jaffe, Elaine S ^a   Emmert Buck, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cancer research; Molecular biology; Pathology; Systems biology; Translational research

Indexed keywords

BIOLOGICAL MARKER; EOSIN; FORMALDEHYDE; HEMATOXYLIN; PARAFFIN; PROTEIN P53; RNA BINDING PROTEIN EWS; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR ERG; WT1 PROTEIN;

ANATOMICAL CONCEPTS; ANGIOGENESIS; ARTICLE; AUTOPSY; BACTERIAL INFECTION; BIOPSY; BLOOD VESSEL; BURKITT LYMPHOMA; CANCER CELL; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CANCER TISSUE; CARCINOGENESIS; CELL LEVEL; CELL POPULATION; CLINICAL PRACTICE; COLD ISCHEMIA; CYTOLOGY; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EPSTEIN BARR VIRUS; EXPERIMENTAL MODEL; FIBROBLAST; FOLLOW UP; FREEZING; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TRACT; GENE FUSION; GENE TRANSLOCATION; HISTOLOGY; HISTOPATHOLOGY; HODGKIN DISEASE; HOLISTIC CARE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFLAMMATION; ISCHEMIA; LABORATORY TEST; LASER CAPTURE MICRODISSECTION; LUNG ADENOCARCINOMA; LYMPHOMA; MACROPHAGE; MEDICAL EDUCATION; MEDICAL HISTORY; MICROSCOPY; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; MORBIDITY; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE MYELOMA; MUTATION; NASOPHARYNX CARCINOMA; NECROSIS; NEOPLASM; NEPHRON; NONHUMAN; ONCOGENE C MYC; ORGAN; OVARY CYST; PATHOLOGY; PATIENT CARE; PRIVACY; PROFESSIONAL SECRECY; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN EXPRESSION; QUALITY CONTROL; SAMPLING; SOFT TISSUE TUMOR; SPINDLE CELL CARCINOMA; THYROID CANCER; TISSUE FIXATION; TISSUE LEVEL; TISSUE PRESERVATION; TUMOR BIOPSY; TUMOR CELL; TUMOR CLASSIFICATION; TUMOR RECURRENCE; UTERINE CERVIX CANCER; VALIDATION STUDY; WART VIRUS;

ANIMALS; HUMANS; MOLECULAR BIOLOGY; NEOPLASMS; PATHOLOGY; SYSTEMS BIOLOGY; TRANSLATIONAL RESEARCH;

EID: 79959264576     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201100017     Document Type: Article

References (68)

1. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57-70.
2. Hahn WC, Weinberg RA. 2002. Rules for making human tumor cells. N Engl J Med 347: 1593-603.
3. Perou CM, Sorlie T, Eisen MB, van de Rijn M, et al. 2000. Molecular portraits of human breast tumours. Nature 406: 747-52.
4. Pfeifer GP, Hainaut P. 2010. Next-generation sequencing: emerging lessons on the origins of human cancer. Curr Opin Oncol 23: 62-8.
5. Iacobuzio-Donahue CA. 2009. Epigenetic changes in cancer. Annu Rev Pathol 4: 229-49.
6. Ma L, Weinberg RA. 2008. MicroRNAs in malignant progression. Cell Cycle 7: 570-2.
7. Schramm G, Kannabiran N, Konig R. 2010. Regulation patterns in signaling networks of cancer. BMC Syst Biol 4: 162.
8. Raghavan K, Ruskin HJ, Perrin D, Goasmat F, et al. 2010. Computational micromodel for epigenetic mechanisms. PLoS One 5: e14031.
9. Aalai E, Gleghorn C, Webb A, Glover SW. 2009. Accessing public health information: a preliminary comparison of CABI's GLOBAL HEALTH database and MEDLINE. Health Info Libr J 26: 56-62.
10. Lander ES, Linton LM, Birren B, Nusbaum C, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921.
11. Weir BA, Woo MS, Getz G, Perner S, et al. 2007. Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-8.
12. Kuhn TS. 1996. The Structure of Scientific Revolutions. 3rd edition. Chicago, IL, USA: University of Chicago Press.
13. Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. 2009. Educational and social-ethical issues in the pursuit of molecular medicine. Mol Med 15: 60-3.
14. Waltz E. 2009. GM crops: battlefield. Nature 461: 27-32.
15. Borrell B. 2010. How accurate are cancer cell lines? Nature 463: 858.
16. Egeblad M, Nakasone ES, Werb Z. 2010. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18: 884-901.
17. Richardson AM, Woodson K, Wang Y, Rodriguez-Canales J, et al. 2007. Global expression analysis of prostate cancer-associated stroma and epithelia. Diagn Mol Pathol 16: 189-97.
18. Steidl C, Lee T, Shah SP, Farinha P, et al. 2010. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 362: 875-85.
19. Compton C. 2007. Getting to personalized cancer medicine: taking out the garbage. Cancer 110: 1641-3.
20. Gillespie JW, Ahram M, Best CJ, Swalwell JI, et al. 2001. The role of tissue microdissection in cancer research. Cancer J 7: 32-9.
21. Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, et al. 2000. Molecular profiling of clinical tissues specimens: feasibility and applications. J Mol Diagn 2: 60-6.
22. Cardiff RD, Rosner A, Hogarth MA, Galvez JJ, et al. 2004. Validation: the new challenge for pathology. Toxicol Pathol 32: 31-9.
23. Ahn AC, Tewari M, Poon CS, Phillips RS. 2006. The limits of reductionism in medicine: Could systems biology offer an alternative? PLoS Med 3: e208.
24. Heng HH. 2008. The conflict between complex systems and reductionism. JAMA 300: 1580-1.
25. Long ER. 1965. A History of Pathology. New York: Dover Publications, Inc.
26. Stenzinger A, Klauschen F, Wittschieber D, Weichert W, et al. 2010. Would Virchow be a systems biologist? A discourse on the philosophy of science with implications for pathological research. Virchows Arch 456: 599-607.
27. Azar HA. 1984. Arthur Purdy Stout (1885-1967). The man and the surgical pathologist. Am J Surg Pathol 8: 301-7.
28. Rosai J. 2004. Rosai and Ackerman's Surgical Pathology, Chapter 1: Historical Perspective. Philadelphia, PA: Mosby (Elsevier).
29. Huvos AG. 1998. James Ewing: cancer man. Ann Diagn Pathol 2: 146-8.
30. Rosai J. 2007. Why microscopy will remain a cornerstone of surgical pathology. Lab Invest 87: 403-8.
31. Talbert ML, Dunn ST, Hunt J, Hillyard DR, et al. 2009. Competency-based education for the molecular genetic pathology fellow: a report of the association for molecular pathology training and education committee. J Mol Diagn 11: 497-507.
32. Igbokwe A, Lopez-Terrada DH. 2011. Molecular testing of solid tumors. Arch Pathol Lab Med 135: 67-82.
33. Barthold SW, Borowsky AD, Brayton C, Bronson R, et al. 2007. From whence will they come? - a perspective on the acute shortage of pathologists in biomedical research. J Vet Diagn Invest 19: 455-6.
34. Couto SS, Cardiff RD. 2008. The genomic revolution and endocrine pathology. Endocr Pathol 19: 139-47.
35. Bova GS, Eltoum IA, Kiernan JA, Siegal GP, et al. 2005. Optimal molecular profiling of tissue and tissue components: defining the best processing and microdissection methods for biomedical applications. Mol Biotechnol 29: 119-52.
36. Leiva IM, Emmert-Buck MR, Gillespie JW. 2003. Handling of clinical tissue specimens for molecular profiling studies. Curr Issues Mol Biol 5: 27-35.
37. Perlmutter MA, Best CJ, Gillespie JW, Gathright Y, et al. 2004. Comparison of snap freezing versus ethanol fixation for gene expression profiling of tissue specimens. J Mol Diagn 6: 371-7.
38. Francz M, Egervari K, Szollosi Z. 2011. Intraoperative evaluation of sentinel lymph nodes in breast cancer: comparison of frozen sections, imprint cytology and immunocytochemistry. Cytopathology 22: 36-42.
39. Erickson HS, Albert PS, Gillespie JW, Rodriguez-Canales J, et al. 2009. Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples. Nat Protoc 4: 902-22.
40. Cardiff RD, Ward JM, Barthold SW. 2008. 'One medicine - one pathology': Are veterinary and human pathology prepared? Lab Invest 88: 18-26.
41. Ince TA, Ward JM, Valli VE, Sgroi D, et al. 2008. Do-it-yourself (DIY) pathology. Nat Biotechnol 26: 978-9.
42. Killian JK, Bilke S, Davis S, Walker RL, et al. 2009. Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. Cancer Res 69: 758-64.
43. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, et al. 1996. Laser capture microdissection. Science 274: 998-1001.
44. Harrell JC, Dye WW, Harvell DM, Sartorius CA, et al. 2008. Contaminating cells alter gene signatures in whole organ versus laser capture microdissected tumors: a comparison of experimental breast cancers and their lymph node metastases. Clin Exp Metastasis 25: 81-8.
45. El-Serag HB, Nurgalieva ZZ, Mistretta TA, Finegold MJ, et al. 2009. Gene expression in Barrett's esophagus: laser capture versus whole tissue. Scand J Gastroenterol 44: 787-95.
46. Klee EW, Erdogan S, Tillmans L, Kosari F, et al. 2009. Impact of sample acquisition and linear amplification on gene expression profiling of lung adenocarcinoma: laser capture micro-dissection cell-sampling versus bulk tissue-sampling. BMC Med Genomics 2: 13.
47. Silvestri A, Colombatti A, Calvert VS, Deng J, et al. 2010. Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Lab Invest 90: 787-96.
48. Eberle FC, Rodriguez-Canales J, Wei L, Hanson JC, et al. 2011. Large scale DNA methylation analysis can distinguish between gray zone lymphoma, classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica 96: 558-66.
49. Eberle FC, Hanson JC, Killian JK, Wei L, et al. 2010. Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J Mol Diagn 12: 394-401.
50. Jaffe ES, Harris NL, Stein H, Isaacson PG. 2008. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 112: 4384-99.
51. Eberle FC, Mani H, Jaffe ES. 2009. Histopathology of Hodgkin's lymphoma. Cancer J 15: 129-37.
52. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, et al. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-8.
53. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, et al. 1997. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404-7.
54. Emmert-Buck MR, Lubensky IA, Dong Q, Manickam P, et al. 1997. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis. Cancer Res 57: 1855-8.
55. Moore PS, Chang Y. 2010. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 10: 878-89.
56. Snow AN, Laudadio J. 2010. Human papillomavirus detection in head and neck squamous cell carcinomas. Adv Anat Pathol 17: 394-403.
57. Pave A. 2010. in Pumain D. (ed), Hierarchy in Natural and Social Sciences (Methodos Series); Hierarchical Organization of Biological and Ecological Systems. pp. 39-70.
58. Chuaqui B. 1995. On the reductionism of sciences. Rev Med Chil 123: 1306-12.
59. Orimo A, Weinberg RA. 2006. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5: 1597-601.
60. Baird L, Terskikh A. 2010. The tumor microenvironment. Adv Exp Med Biol 671: 67-73.
61. Mbeunkui F, Johann DJ, Jr. 2009. Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol 63: 571-82.
62. Letterer E. 1959. Allgemeine Pathologie, Grundlagen und Probleme: ein Lehrbuch. Stuttgart: Georg Thieme Verlag.
63. Kitamura H. 1964. The fine structure of lung alveoli and its reactions. (Histopathological studies by electron microscope). Acta Pathol Jpn 14: 147-66.
64. Gossner W. 2003. Target cells in internal dosimetry. Radiat Prot Dosimetry 105: 39-42.
65. Costa J. 2008. Is clinical systems pathology the future of pathology? Arch Pathol Lab Med 132: 774-6.
66. Donovan MJ, Costa J, Cordon-Cardo C. 2009. Systems pathology: a paradigm shift in the practice of diagnostic and predictive pathology. Cancer 115: 3078-84.
67. Donovan MJ, Kotsianti A, Bayer-Zubek V, Verbel D, et al. 2009. A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib. Eur J Cancer 45: 1518-26.
68. Armstrong S. 2008. A Matter of Life and Death, Conversations with Pathologists. p. 107